T1	PROC 46 68	Ensayo clínico fase II
#1	AnnotatorNotes T1	C0282460; Phase 2 Clinical Trials; Research Activity
T2	PROC 74 100	evaluar la farmacocinética
T3	PROC 108 125	pauta antibiótica
T4	PROC 139 174	tratamiento antibiótico intravenoso
T5	DISO 194 243	endocarditis infecciosa por Enterococcus faecalis
#2	AnnotatorNotes T5	C0857843; Enterococcus faecalis endocarditis; Disease or Syndrome
T6	DISO 286 335	endocarditis infecciosa por Enterococcus faecalis
#3	AnnotatorNotes T6	C0857843; Enterococcus faecalis endocarditis; Disease or Syndrome
T7	PROC 680 698	valores analíticos
T8	PROC 488 491	IMC
#4	AnnotatorNotes T8	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T9	ANAT 788 796	hepático
#5	AnnotatorNotes T9	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T10	ANAT 805 810	renal
#6	AnnotatorNotes T10	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T11	PROC 812 821	hemograma
#7	AnnotatorNotes T11	C0009555; Complete Blood Count; Laboratory Procedure
T12	PROC 757 779	parámetros bioquímicos
T13	PROC 951 969	exploración física
#8	AnnotatorNotes T13	C0031809; Physical Examination; Health Care Activity
T14	PROC 574 598	consentimiento informado
#9	AnnotatorNotes T14	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T15	PROC 1127 1138	tratamiento
#10	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	PROC 1168 1177	prescrito
#11	AnnotatorNotes T16	C0033080; Prescription procedure; Health Care Activity | C2239117; Prescription of drug (procedure); Health Care Activity
T17	PROC 1183 1191	evaluado
#12	AnnotatorNotes T17	C0220825; Evaluation; Health Care Activity
T18	PROC 1460 1470	examinados
T19	DISO 1252 1265	interacciones
#13	AnnotatorNotes T19	C0687133; Drug Interactions; Pathologic Function
T20	PROC 1380 1403	análisis de laboratorio
#14	AnnotatorNotes T20	C0022885; Laboratory Procedures; Laboratory Procedure
T21	PROC 1412 1430	exploración física
#15	AnnotatorNotes T21	C0031809; Physical Examination; Health Care Activity
T22	DISO 1331 1344	anormalidades
#16	AnnotatorNotes T22	C1704258; Abnormality; Finding
T23	DISO 1558 1567	infección
#17	AnnotatorNotes T23	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T24	PROC 1593 1602	screening
#18	AnnotatorNotes T24	C0220908; Screening procedure; Diagnostic Procedure
T25	PROC 781 796	perfil hepático
#19	AnnotatorNotes T25	C0023901; Liver Function Tests; Laboratory Procedure
T26	PROC 798 810	perfil renal
T27	PROC 1800 1811	tratamiento
#20	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	PROC 1925 1934	protocolo
#21	AnnotatorNotes T28	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T29	DISO 1956 1963	alergia
#22	AnnotatorNotes T29	C1527304; Allergic Reaction; Pathologic Function
T30	DISO 1966 1983	hipersensibilidad
#23	AnnotatorNotes T30	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T31	CHEM 2003 2014	penicilinas
#24	AnnotatorNotes T31	C0030842; penicillins; Antibiotic · Organic Chemical
T32	DISO 2035 2056	enfermedades cutáneas
#25	AnnotatorNotes T32	C0037274; Dermatologic disorders; Disease or Syndrome
T33	PROC 2155 2166;2183 2207	por escrito consentimiento informado
#26	AnnotatorNotes T33	C0811741; Obtain informed written consent; Health Care Activity
T34	CHEM 114 125	antibiótica
#27	AnnotatorNotes T34	C0003232; Antibiotics; Antibiotic
T35	CHEM 151 162	antibiótico
#28	AnnotatorNotes T35	C0003232; Antibiotics; Antibiotic
T36	PROC 463 486	índice de masa corporal
#29	AnnotatorNotes T36	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T37	ANAT 478 486	corporal
#30	AnnotatorNotes T37	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T38	PROC 824 832	albúmina
#31	AnnotatorNotes T38	C0201838; Albumin measurement; Laboratory Procedure
T39	PROC 1055 1065	examinados
T40	CHEM 1273 1284	ceftriaxona
#32	AnnotatorNotes T40	C0007561; ceftriaxone; Antibiotic · Organic Chemical
T41	DISO 1640 1670	condición clínica o quirúrgica
T42	CHEM 1816 1830	cefalosporinas
#33	AnnotatorNotes T42	C3536856; Cephalosporins; Antibiotic · Organic Chemical
T43	CHEM 1986 2000	cefalosporinas
#34	AnnotatorNotes T43	C3536856; Cephalosporins; Antibiotic · Organic Chemical
T44	ANAT 2048 2056	cutáneas
#35	AnnotatorNotes T44	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T45	PROC 2094 2124	administración del tratamiento
T46	Date 13 17	2017
T47	PHYS 85 100	farmacocinética
#36	AnnotatorNotes T47	C0031327; Drug Kinetics; Physiologic Function
T48	Route 163 174	intravenoso
#37	AnnotatorNotes T48	C1522726; Intravenous Route of Drug Administration; Functional Concept
T49	LIVB 222 243	Enterococcus faecalis
#38	AnnotatorNotes T49	C0038404; Enterococcus faecalis; Bacterium
T50	LIVB 267 284	Voluntarios sanos
#39	AnnotatorNotes T50	C1708335; Healthy Volunteers; Population Group
T51	LIVB 314 335	Enterococcus faecalis
#40	AnnotatorNotes T51	C0038404; Enterococcus faecalis; Bacterium
T52	LIVB 366 373	Sujetos
#41	AnnotatorNotes T52	C0681850; Study Subject; Group
T55	LIVB 375 400	hombres o mujeres adultos
#42	AnnotatorNotes T55	C0025266; Male population group; Population Group + C0043210; Woman; Population Group + C0001675; Adult; Age Group
T57	LIVB 519 525	sujeto
#43	AnnotatorNotes T57	C0681850; Study Subject; Group
T58	LIVB 531 544	representante
#44	AnnotatorNotes T58	C0030701; Patient Representatives; Professional or Occupational Group | C0600419; Patient Agent; Group | C1998038; Patient advocate (person); Population Group (?)
T59	LIVB 655 662	sujetos
#45	AnnotatorNotes T59	C0681850; Study Subject; Group
T62	LIVB 838 847	pacientes
#46	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	LIVB 927 934	sujetos
#47	AnnotatorNotes T63	C0681850; Study Subject; Group
T65	LIVB 1039 1048	pacientes
#48	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	LIVB 1155 1161	sujeto
#49	AnnotatorNotes T66	C0681850; Study Subject; Group
T67	Spec_cue 1243 1251	posibles
T68	LIVB 1319 1326	sujetos
#50	AnnotatorNotes T68	C0681850; Study Subject; Group
T69	LIVB 1444 1453	pacientes
#51	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	LIVB 1533 1540	sujetos
#52	AnnotatorNotes T70	C0681850; Study Subject; Group
T71	LIVB 1611 1618	sujetos
#53	AnnotatorNotes T71	C0681850; Study Subject; Group
T72	LIVB 1773 1780	sujetos
#54	AnnotatorNotes T72	C0681850; Study Subject; Group
T73	Duration 1834 1845	los 21 días
T74	LIVB 1944 1951	sujetos
#55	AnnotatorNotes T74	C0681850; Study Subject; Group
T75	LIVB 2023 2030	sujetos
#56	AnnotatorNotes T75	C0681850; Study Subject; Group
T76	Duration 2057 2065	crónicas
#57	AnnotatorNotes T76	C0205191; chronic; Temporal Concept
T77	Neg_cue 2079 2081	no
T78	LIVB 2133 2140	sujetos
#58	AnnotatorNotes T78	C0681850; Study Subject; Group
T79	Neg_cue 2145 2147	no
T53	LIVB 869 877	personal
#59	AnnotatorNotes T53	C1704312; Health professional; Professional or Occupational Group
T54	LIVB 1070 1078	personal
#60	AnnotatorNotes T54	C1704312; Health professional; Professional or Occupational Group
T56	LIVB 1196 1204	personal
#61	AnnotatorNotes T56	C1704312; Health professional; Professional or Occupational Group
T60	LIVB 1475 1483	personal
#62	AnnotatorNotes T60	C1704312; Health professional; Professional or Occupational Group
T61	LIVB 1715 1723	personal
#63	AnnotatorNotes T61	C1704312; Health professional; Professional or Occupational Group
T64	PROC 405 409	Peso
#64	AnnotatorNotes T64	C2985231; Body Weight Measurement; Diagnostic Procedure
A1	Population_data T55 Age
A2	Assertion T19 Speculated
A3	Assertion T45 Negated
A4	Assertion T33 Negated
A5	Status T29 History_of
A6	Status T30 History_of
#65	AnnotatorNotes T2	C0201734; Pharmacokinetic study; Research Activity
#66	AnnotatorNotes T4	C0559680; Intravenous antibiotic therapy; Therapeutic or Preventive Procedure 
#67	AnnotatorNotes T26	C0278356; Kidney panel; Laboratory Procedure 
#68	AnnotatorNotes T39	C0220825; Evaluation; Health Care Activity
#69	AnnotatorNotes T18	C0220825; Evaluation; Health Care Activity
T80	Neg_cue 720 723	sin
T81	Neg_cue 1011 1014	sin
T82	Observation 724 742	relevancia clínica
A7	Assertion T82 Negated
T83	Observation 1015 1033	relevancia clínica
A8	Assertion T83 Negated
R1	Used_for Arg1:T34 Arg2:T3	
R2	Used_for Arg1:T35 Arg2:T4	
R3	Has_Route_or_Mode Arg1:T35 Arg2:T48	
T84	Quantifier_or_Qualifier 175 187	domiciliario
#70	AnnotatorNotes T84	C0338047; Domiciliary; Spatial Concept 
R4	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T84	
R5	Causes Arg1:T49 Arg2:T5	
R6	Causes Arg1:T51 Arg2:T6	
R7	Experiences Arg1:T50 Arg2:T6	
T85	Result_or_Value 410 444	mínimo de 40 kg y máximo de 105 kg
R8	Has_Result_or_Value Arg1:T64 Arg2:T85	
R9	Location_of Arg1:T37 Arg2:T36	
R10	Location_of Arg1:T37 Arg2:T8	
T86	Result_or_Value 493 511	menor de 34 kg /m2
R11	Has_Result_or_Value Arg1:T36 Arg2:T86	
R12	Has_Result_or_Value Arg1:T8 Arg2:T86	
R13	Negation Arg1:T80 Arg2:T82	
R14	Experiences Arg1:T59 Arg2:T7	
#71	AnnotatorNotes T82	C2826293; Clinical Relevance; Finding
#72	AnnotatorNotes T83	C2826293; Clinical Relevance; Finding
R15	Negation Arg1:T81 Arg2:T83	
R16	Location_of Arg1:T9 Arg2:T25	
R17	Location_of Arg1:T10 Arg2:T26	
R18	Experiences Arg1:T59 Arg2:T12	
R20	Experiences Arg1:T59 Arg2:T25	
R21	Experiences Arg1:T59 Arg2:T26	
R22	Experiences Arg1:T59 Arg2:T11	
R23	Experiences Arg1:T59 Arg2:T38	
T87	Result_or_Value 699 707	normales
#73	AnnotatorNotes T87	C0459422; Normal result; Finding | C0586624; Normal laboratory finding; Finding
R24	Has_Result_or_Value Arg1:T7 Arg2:T87	
T88	Result_or_Value 710 719	anormales
#74	AnnotatorNotes T88	C3648370; laboratory tests nonspecific abnormal findings; Finding
R25	Has_Result_or_Value Arg1:T7 Arg2:T88	
#75	AnnotatorNotes T12	C0430027; biochemical test; Laboratory Procedure (?)
R19	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T87	
R26	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T88	
R27	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T87	
R28	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T88	
R29	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T87	
R30	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T88	
R31	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T87	
R32	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T88	
R33	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T87	
R34	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T88	
T89	PROC 854 864	examinados
#76	AnnotatorNotes T89	C0582103; Medical Examination; Health Care Activity
R35	Experiences Arg1:T62 Arg2:T89	
R36	Experiences Arg1:T63 Arg2:T13	
T90	Quantifier_or_Qualifier 970 977	inicial
#77	AnnotatorNotes T90	C0205265; Initially; Temporal Concept
R37	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T90	
T91	Result_or_Value 978 984	normal
#78	AnnotatorNotes T91	C0459422; Normal result; Finding
R38	Has_Result_or_Value Arg1:T13 Arg2:T91	
T92	Observation 991 1010	hallazgos anormales
#79	AnnotatorNotes T92	C2826279; Abnormal Finding; Finding 
R39	Overlap Arg1:T13 Arg2:T92	
R40	Experiences Arg1:T63 Arg2:T92	
R41	Experiences Arg1:T65 Arg2:T39	
R42	Experiences Arg1:T66 Arg2:T15	
R43	Experiences Arg1:T66 Arg2:T19	
R44	Speculation Arg1:T67 Arg2:T19	
R45	Causes Arg1:T40 Arg2:T19	
R46	Before Arg1:T16 Arg2:T15	
R47	Experiences Arg1:T68 Arg2:T22	
T93	Quantifier_or_Qualifier 1345 1372	clínicamente significativas
R48	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T93	
R49	Experiences Arg1:T68 Arg2:T20	
R50	Experiences Arg1:T68 Arg2:T21	
T94	Quantifier_or_Qualifier 1431 1438	inicial
#80	AnnotatorNotes T94	C0205265; Initially; Temporal Concept
R53	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T94	
R54	Experiences Arg1:T69 Arg2:T18	
R55	Experiences Arg1:T70 Arg2:T23	
R57	Experiences Arg1:T70 Arg2:T24	
T95	Quantifier_or_Qualifier 1568 1574	activa
#81	AnnotatorNotes T95	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R58	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T95	
R59	Experiences Arg1:T71 Arg2:T41	
T96	CONC 1692 1701	inclusión
A9	Assertion T96 Contraindicated
#82	AnnotatorNotes T96	C1512693; Inclusion; Qualitative Concept
R60	Before Arg1:T41 Arg2:T96	
R61	Experiences Arg1:T72 Arg2:T27	
R62	Used_for Arg1:T42 Arg2:T27	
R63	Overlap Arg1:T42 Arg2:T73	
T97	CONC 1857 1874	inicio del ensayo
#83	AnnotatorNotes T97	C4684789; Study Start; Temporal Concept | C2349982; Study start time; Temporal Concept
R64	Before Arg1:T27 Arg2:T97	
T98	PROC 1868 1874	ensayo
#84	AnnotatorNotes T98	C0008976; Clinical Trials; Research Activity
R65	Overlap Arg1:T27 Arg2:T98	
R66	Experiences Arg1:T74 Arg2:T29	
R67	Experiences Arg1:T74 Arg2:T30	
R68	Causes Arg1:T43 Arg2:T29	
R69	Causes Arg1:T43 Arg2:T30	
R70	Causes Arg1:T31 Arg2:T29	
R71	Causes Arg1:T31 Arg2:T30	
R72	Experiences Arg1:T75 Arg2:T32	
R73	Location_of Arg1:T44 Arg2:T32	
R74	Has_Duration_or_Interval Arg1:T32 Arg2:T76	
R75	Negation Arg1:T77 Arg2:T45	
T99	Quantifier_or_Qualifier 2068 2074	agudas
#85	AnnotatorNotes T99	C0439557; Acute phase; Temporal Concept
R76	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T99	
R77	Experiences Arg1:T75 Arg2:T45	
R78	Negation Arg1:T79 Arg2:T33	
#86	AnnotatorNotes T45	C3469597; Administration of medication; Therapeutic or Preventive Procedure
#87	AnnotatorNotes T93	C5209294; Clinical relevance; Intellectual Product
#88	AnnotatorNotes T3	C0338237; Antibiotic therapy; Therapeutic or Preventive Procedure (?)
A10	Experiencer T50 Patient
A11	Experiencer T55 Patient
A12	Experiencer T52 Patient
A13	Experiencer T57 Patient
A14	Experiencer T58 Other
A15	Experiencer T59 Patient
A16	Experiencer T62 Patient
A17	Experiencer T53 Other
A18	Experiencer T63 Patient
A19	Experiencer T65 Patient
A20	Experiencer T54 Other
A21	Experiencer T66 Patient
A22	Experiencer T56 Other
A23	Experiencer T68 Patient
A24	Experiencer T60 Other
A25	Experiencer T69 Patient
A26	Experiencer T70 Patient
A27	Experiencer T71 Patient
A28	Experiencer T61 Other
A29	Experiencer T72 Patient
A30	Experiencer T74 Patient
A31	Experiencer T75 Patient
A32	Experiencer T78 Patient
A33	Status T89 Future
A34	Status T39 Future
A35	Status T17 Future
A36	Status T18 Future
